NCT05031806 Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease Status COMPLETED Phase PHASE1
NCT05003128 Changes in Tear Lipid Layer Thickness After Short Exposure to Light Emitting Diode Displays Status COMPLETED Phase NA
NCT04970329 Corneal Thickness Changes in Patient Undergoing Dry Eye Managment Status UNKNOWN Phase NA
NCT04946721 2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD Status RECRUITING Phase N/A
NCT04819269 Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome Status COMPLETED Phase PHASE3
NCT04785261 Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease Status UNKNOWN Phase PHASE2
NCT04762355 Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT04735393 A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE3
NCT04734210 Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease Status COMPLETED Phase PHASE2
NCT04734197 A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE2
NCT04711642 Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery Status UNKNOWN Phase PHASE3
NCT04683796 Comparison of Efficacy Between 100% Platelet-rich Plasma and 100% Serum Eye Drops in Dry Eye Disease Status COMPLETED Phase PHASE3
NCT04673643 Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease Status RECRUITING Phase PHASE2
NCT04670263 Evaluating the Efficacy of Dry Eye (DE) Disease Treatment Using Novel Tear Film Imager (TFI) Status COMPLETED Phase PHASE2/PHASE3
NCT04645446 Safety and Efficacy of Two Different Concentrations (0.5% and 1%) of Progesterone Topical Gel Compared to Placebo in Patients Diagnosed With Moderate to Severe Dry Eye Syndrome Status COMPLETED Phase PHASE2
NCT04633863 Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation Status COMPLETED Phase NA